ClinicalTrials.gov
public full text
Public Domain
Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo
The study aims to evaluate the safety and efficacy of the combination of topical baricitinib and 308-nm monochromatic excimer light versus 308-nm monochromatic excimer light alone in treatment of non-segmental vitiligo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- COMBINATII (PIROXICAM; CICLOBENZAPINA; LIDOCAINA) 5MG+5MG+20MG 50 G#166416
- COMBINATII ( PERINDOPRIL ARGININA + INDAPAMID + AMLODIPINA ) TRIPLIXAM 5MG/ 1.25MG/ 5MG#166407
- Development of Minimally-Invasive Optical Methods to Individualize the Doses Used for Therapeutic Applications of Light#1100205
- Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin#1090869
- The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa#1100968
Record · ID 845890
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive